Live Breaking News & Updates on Rhonda farnum

Stay informed with the latest breaking news from Rhonda farnum on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rhonda farnum and stay connected to the pulse of your community

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to Theravance Biopharma’s Third Quarter 2023 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal remarks. [Operator Instructions] Also, today’s […]

China , Theravance-biopharma , Rick-winningham , Rhonda-farnum , Aziz-sawaf , Semiconductor-stocks-to-buy , Gold-report , Semiconductor-stocks-to-buy-now , Electric-utility-stocks-to-buy , Ick-graham , Ick-winningham , Ypress

Martingale Asset Management L P Invests $682,000 in Theravance Biopharma, Inc. (NASDAQ:TBPH)

Martingale Asset Management L P acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 60,742 shares of the biopharmaceutical company’s stock, valued at approximately $682,000. Martingale Asset Management L […]

Canada , Richarda-graham , Rhonda-farnum , Theravance-biopharma , Nasdaq , Theravance-biopharma-inc , Acadian-asset-management , Exchange-commission , Royal-bank , Securities-exchange-commission , Get-rating , Capital-management

Opaleye Management Inc. Takes Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)

Opaleye Management Inc. acquired a new stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 87,600 shares of the biopharmaceutical company’s stock, valued at approximately $983,000. Opaleye Management […]

Switzerland , Swiss , Richarda-graham , Theravance-biopharma , Rhonda-farnum , Exchange-commission , Swiss-national-bank , Securities-exchange-commission , Theravance-biopharma-inc , Allspring-global-investments-holdings , Nasdaq , Opaleye-management-inc

Theravance Biopharma (NASDAQ:TBPH) Shares Down 5%

Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) dropped 5% during trading on Wednesday . The company traded as low as $10.55 and last traded at $10.55. Approximately 98,089 shares changed hands during trading, a decline of 80% from the average daily volume of 498,166 shares. The stock had previously closed at $11.11. Analyst Upgrades and […]

Theravance-biopharma , Rhonda-farnum , Richarda-graham , Deutsche-bank , Geode-capital-management , Nasdaq , Pricet-rowe-associates-inc , Theravance-biopharma-inc , Ensign-peak-advisors-inc , Securities-exchange-commission , Theravance-biopharma-company-profile , Get-rating

Theravance Biopharma (NASDAQ:TBPH) Price Target Raised to $20.00

Theravance Biopharma (NASDAQ:TBPH – Get Rating) had its price objective lifted by HC Wainwright from $19.00 to $20.00 in a research report sent to investors on Tuesday morning, The Fly reports. HC Wainwright also issued estimates for Theravance Biopharma’s Q2 2023 earnings at ($0.27) EPS, Q3 2023 earnings at ($0.17) EPS, Q4 2023 earnings at […]

Canada , Richarda-graham , Rhonda-farnum , Theravance-biopharma , Royal-bank , Theravance-biopharma-inc , Theravance-biopharma-company-profile , Get-rating , Capital-management , Theravance-biopharma-daily , Nasdaq-tbph , Tbph

Theravance Biopharma (NASDAQ:TBPH) Price Target Increased to $20.00 by Analysts at HC Wainwright

Theravance Biopharma (NASDAQ:TBPH – Get Rating) had its price objective boosted by HC Wainwright from $19.00 to $20.00 in a report published on Tuesday, The Fly reports. Separately, StockNews.com began coverage on Theravance Biopharma in a report on Thursday, March 16th. They set a hold rating for the company. Theravance Biopharma Stock Performance Shares of […]

Theravance-biopharma , Rhonda-farnum , Richarda-graham , Acadian-asset-management , Principal-financial-group-inc , Theravance-biopharma-company-profile , Charles-schwab-investment-management-inc , Securities-exchange-commission , Vanguard-group-inc , Theravance-biopharma-inc , Get-rating , Exchange-commission

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Biopharma First Quarter 2023 Conference Call.

United-states , Aziz-sawaf , Theravance-biopharma , Liisa-bayko , Rick-graham , Jim-kelly , Rick-winningham , Susannah-gray , Rhonda-farnum , Divya-rao , David-risinger , Theravance-biopharma-inc

Theravance Biopharma, Inc. (TBPH) Q3 2022 Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:NASDAQ:TBPH) Q3 2022 Earnings Conference Call November 7, 2022 05:00 PM ET Company Participants Rick Winningham – Chairman and Chief Executive Officer...

Netherlands , United-states , New-york , American , Dutch , Rick-winningham , Rhonda-farnum , David-risinger , Douglas-tsao , Rick-graham , Brian-skorney , Eva-privitera